Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

M-ESLON

ETHYPHARM INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is M-ESLON discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that M-ESLON 200MG has been permanently discontinued (last updated August 30, 2017). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is M-ESLON not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file6 products
Affected strength200MG
Last updated2017-08-30

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

⚠ Extended-release and immediate-release formulations are not interchangeable — confirm the release type with your pharmacist before switching.

Other Products

STATEX

KNIGHT THERAPEUTICS INC.

5MG · DIN 00594652

Different strengthDifferent dosage formSame routeNo current shortage

MS.IR

PURDUE PHARMA

10MG · DIN 02014211

Different strengthDifferent dosage formSame routeNo current shortage

MS CONTIN

PURDUE PHARMA

60MG · DIN 02014300

Different strengthDifferent dosage formSame routeNo current shortage

M-ESLON

ETHYPHARM INC

30MG · DIN 02019949

Different strengthDifferent dosage formSame routeNo current shortage

M.O.S. SULPHATE 50MG TAB

VALEANT CANADA LP / VALEANT CANADA S.E.C.

50MG · DIN 02009706

Different strengthDifferent dosage formSame routeNo current shortage

ORAMORPH SR TABLETS 100MG

Extended-Release

ROXANE LABS, DIVISION OF BOEHRINGER INGELHEIM

100MG · DIN 01988743

Different strengthDifferent dosage formSame routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

⚠ Possible Recall or Safety Alert

Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.

DIN

02177757

Strength

200MG

Dosage Form

CAPSULE (EXTENDED RELEASE)

Route

ORAL

Active Ingredient

MORPHINE SULFATE

See all MORPHINE SULFATE products →

Shortage History